Evidence map›Paper›PMID 20581455›Full record

ArticleCell cycle (Georgetown, Tex.)2010

Disruption of calvarial ossification in E2f4 mutant embryos correlates with increased proliferation and progenitor cell populations.

Emily S Miller, Seth D Berman, Tina L Yuan, Jacqueline A Lees

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. E2F8 as a Novel Therapeutic Target for Lung Cancer.Journal of the National Cancer Institute · 2015
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Emily S MillerDavid H. Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA.
Seth D Berman
Tina L Yuan
Jacqueline A Lees
Massachusetts Institute of Technology · US

Funding

E2F AND THE CONTROL OF CELLULAR PROLIFERATIONR01GM053204 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI LEES, JACQUELINE A. · 1997 to 2005
$1.8M
E2F4 and RB in differentiation control and tumorigenesisR01CA121921 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI LEES, JACQUELINE A. · 2006 to 2010
$1.6M
NCI NIH HHS CA121921NCI NIH HHS R01 CA121921NIGMS NIH HHS GM53204NIGMS NIH HHS R01 GM053204
6 · The paper itself

Abstract

The E2F family of transcription factors, in association with pocket protein family members, are important for regulating genes required for cellular proliferation. The most abundant E2F, E2F4, is implicated in maintaining the G(0)/G(1) cell cycle state via transcriptional repression of genes that encode proteins required for S-phase progression. Here, we investigate E2F4's role in bone development using E2f4 germline mutant mice. We find that mutation of E2f4 impairs the formation of several bones that arise through intramembranous or endochondral ossification. The most severe defect occurred in the calvarial bones of the skull where we observed a striking delay in their ossification. In vivo and in vitro analyses established that E2F4 loss did not block the intrinsic differentiation potential of calvarial osteoblast progenitors. However, our data showed that E2f4 mutation elevated proliferation in the developing calvaria in vivo and it increased the endogenous pool of undifferentiated progenitor cells. These data suggest that E2F4 plays an important role in enabling osteoblast progenitors to exit the cell cycle and subsequently differentiate thereby contributing to the commitment of these cells to the bone lineage.

Indexed as

OsteogenesisAlkaline PhosphataseAnimalsBone MatrixCartilageCell ProliferationE2F4 Transcription FactorEmbryo, MammalianMiceMice, Mutant StrainsMutationOsteoblastsSkullStem CellsAlkaline PhosphataseE2f4 protein, mouseE2F4 Transcription Factor

Identifiers

PMID20581455
PMCPMC3322454
OpenAlexW2024398314

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.